226 related articles for article (PubMed ID: 16980582)
1. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
Shchors K; Shchors E; Rostker F; Lawlor ER; Brown-Swigart L; Evan GI
Genes Dev; 2006 Sep; 20(18):2527-38. PubMed ID: 16980582
[TBL] [Abstract][Full Text] [Related]
2. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.
Soucek L; Lawlor ER; Soto D; Shchors K; Swigart LB; Evan GI
Nat Med; 2007 Oct; 13(10):1211-8. PubMed ID: 17906636
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.
Pelengaris S; Khan M; Evan GI
Cell; 2002 May; 109(3):321-34. PubMed ID: 12015982
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
5. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
6. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G
Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716
[TBL] [Abstract][Full Text] [Related]
8. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.
Knies-Bamforth UE; Fox SB; Poulsom R; Evan GI; Harris AL
Cancer Res; 2004 Sep; 64(18):6563-70. PubMed ID: 15374969
[TBL] [Abstract][Full Text] [Related]
9. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
[TBL] [Abstract][Full Text] [Related]
10. The Rip1Tag2 Transgenic Mouse Model.
Bill R; Christofori G
Methods Mol Biol; 2016; 1464():151-161. PubMed ID: 27858364
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
Inoue M; Hager JH; Ferrara N; Gerber HP; Hanahan D
Cancer Cell; 2002 Mar; 1(2):193-202. PubMed ID: 12086877
[TBL] [Abstract][Full Text] [Related]
12. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.
Huang YT; Lan Q; Ponsonnet L; Blanquet M; Christofori G; Zaric J; Rüegg C
Oncotarget; 2016 Jan; 7(2):1663-74. PubMed ID: 26625209
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
14. An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.
Ngo CV; Gee M; Akhtar N; Yu D; Volpert O; Auerbach R; Thomas-Tikhonenko A
Cell Growth Differ; 2000 Apr; 11(4):201-10. PubMed ID: 10775037
[TBL] [Abstract][Full Text] [Related]
15. The role of IL-1β in the early tumor cell-induced angiogenic response.
Carmi Y; Dotan S; Rider P; Kaplanov I; White MR; Baron R; Abutbul S; Huszar M; Dinarello CA; Apte RN; Voronov E
J Immunol; 2013 Apr; 190(7):3500-9. PubMed ID: 23475218
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
17. Induction of angiogenesis during the transition from hyperplasia to neoplasia.
Folkman J; Watson K; Ingber D; Hanahan D
Nature; 1989 May; 339(6219):58-61. PubMed ID: 2469964
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
19. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
[TBL] [Abstract][Full Text] [Related]
20. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
